The results show a lower level of ANGPTL7 in patients with none or mild OSA while a significant elevation was shown in circulating ANGPTL7 and an increased expression of ANGPTL7 in subcutaneous white adipose tissue in patients with moderate-to-severe OSA. This evidence concerns the gene ANGPTL7 and obstructive sleep apnea syndrome.